Assessing residual cancer cells using MRI and US after preoperative chemotherapy in primary breast cancer to omit surgery

Ultrasound is at least as good as magnetic resonance imaging in predicting tumour size post-neoadjuvant chemotherapy in breast cancer

(2016) Birgit E.P.J. Vriens et al.   EUROPEAN JOURNAL OF CANCER

Predictors of Chemosensitivity in Triple Negative Breast Cancer: An Integrated Genomic Analysis

(2016) Tingting Jiang et al.   PLOS MEDICINE

Clinicopathologic Significance of the Intratumoral Heterogeneity of HER2 Gene Amplification in HER2-Positive Breast Cancer Patients Treated With Adjuvant Trastuzumab

(2015) Hee Jin Lee et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer

(2014) Hee Jin Lee et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Definition and Impact of Pathologic Complete Response on Prognosis After Neoadjuvant Chemotherapy in Various Intrinsic Breast Cancer Subtypes

(2012) Gunter von Minckwitz et al.   JOURNAL OF CLINICAL ONCOLOGY

Accuracy of MRI in Prediction of Pathologic Complete Remission in Breast Cancer After Preoperative Therapy: A Meta-Analysis

(2010) Ying Yuan et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

MRI-Model to Guide the Surgical Treatment in Breast Cancer Patients After Neoadjuvant Chemotherapy

(2010) Marieke E. Straver et al.   ANNALS OF SURGERY

Preoperative Chemotherapy: Updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27

(2008) Priya Rastogi et al.   JOURNAL OF CLINICAL ONCOLOGY